Ekso Bionics Holdings, Inc. (EKSO)

Ekso Bionics Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	8.29	8.64	20.53	40.41	12.86	10.87
Cash & Short-Term Investments	8.29	8.64	20.53	40.41	12.86	10.87
Cash Growth	-16.55%	-57.91%	-49.20%	214.15%	18.30%	42.02%
Receivables	6.96	5.65	4.63	4.66	3.22	5.21
Inventory	5.03	5.05	5.19	2.24	1.98	2.49
Prepaid Expenses	0.78	0.88	0.7	0.49	0.36	0.24
Total Current Assets	21.07	20.21	31.04	47.8	18.42	18.81
Property, Plant & Equipment	2.52	3	3.99	1.21	1.86	2.74
Goodwill	0.43	0.43	0.43	-	-	0.19
Other Intangible Assets	4.66	4.89	5.22	-	-	-
Other Long-Term Assets	0.53	0.39	0.23	0.16	0.32	0.18
Total Assets	29.21	28.92	40.9	49.17	20.6	21.92
Accounts Payable	1.81	1.85	3.15	3.11	1.5	1.9
Accrued Expenses	1.53	2.2	2	2.1	1.24	1.4
Current Portion of Long-Term Debt	1.25	1.25	2.31	-	-	2.33
Current Portion of Leases	0.43	0.36	0.34	0.23	0.55	0.42
Current Unearned Revenue	2.04	1.99	1.12	1.22	1.5	1.49
Other Current Liabilities	0.44	0.46	0.27	0.2	0.19	0.29
Total Current Liabilities	7.51	8.12	9.2	6.86	4.97	7.83
Long-Term Debt	4.11	4.83	3.77	1.99	3.08	0.41
Long-Term Leases	0.56	0.72	1.09	-	0.23	0.71
Long-Term Unearned Revenue	1.97	2.17	1.03	1.48	1.81	1.79
Other Long-Term Liabilities	0.2	0.47	0.37	1.62	6.08	4.38
Total Liabilities	14.34	16.31	15.46	11.95	16.16	15.12
Common Stock	0.02	0.02	0.01	0.01	0.01	0.01
Additional Paid-In Capital	261.9	251.58	248.81	246.09	204.38	190.02
Retained Earnings	-247.06	-239.15	-223.95	-208.87	-199.1	-183.28
Comprehensive Income & Other	0.01	0.16	0.56	-0.02	-0.85	0.05
Total Common Equity	14.87	12.61	25.44	37.22	4.43	6.8
Shareholders' Equity	14.87	12.61	25.44	37.22	4.43	6.8
Total Liabilities & Equity	29.21	28.92	40.9	49.17	20.6	21.92
Total Debt	6.35	7.17	7.51	2.22	3.86	3.87
Net Cash (Debt)	1.95	1.47	13.02	38.18	9.01	7
Net Cash Growth	-20.67%	-88.71%	-65.90%	323.98%	28.66%	165.25%
Net Cash Per Share	0.11	0.11	1.00	3.11	1.26	1.46
Filing Date Shares Outstanding	22	17.9	13.34	12.69	12.6	5.8
Total Common Shares Outstanding	22	14.85	13.2	12.69	8.35	5.79
Working Capital	13.56	12.09	21.84	40.94	13.45	10.98
Book Value Per Share	0.68	0.85	1.93	2.93	0.53	1.17
Tangible Book Value	9.78	7.28	19.79	37.22	4.43	6.61
Tangible Book Value Per Share	0.44	0.49	1.50	2.93	0.53	1.14
Machinery	-	4.76	5.3	4.71	4.35	4.4
Leasehold Improvements	-	0.18	0.14	0.63	0.63	0.63
Order Backlog	-	1.51	-	-	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.